Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

An automated cell culture system reduces hands-on time and improves seeding consistency in 96-well microplates. The research ...

A pigment that makes feathers and hair orange helps prevent cellular damage by removing excess cysteine from cells.

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

New Review Integrates Human, Animal, and Cellular Evidence to Reframe AD as a Triad-Centered Disorder Alzheimer’s disease (AD ...

Let’s check what we’ve heard and what we think we know against the science.

Wearable health devices, such as smartwatches, have become commonplace, enabling the continuous monitoring of physiological ...

Rates of multiple myeloma, the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published by Wiley online in CANCER provides ...

In the first study of its kind that uses high-scale real-world data, ChatGPT and other Large Language Models were tested on ...

Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antib ...